Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA538475
Max Phase: Preclinical
Molecular Formula: C33H44ClN5O5
Molecular Weight: 589.74
Molecule Type: Small molecule
Associated Items:
ID: ALA538475
Max Phase: Preclinical
Molecular Formula: C33H44ClN5O5
Molecular Weight: 589.74
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H](NC(=O)C1CCCCC1)C(=O)N(C)[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1ccccn1)C(=O)O.Cl
Standard InChI: InChI=1S/C33H43N5O5.ClH/c1-21(2)17-27(36-30(39)22-11-5-4-6-12-22)32(41)38(3)29(18-23-20-35-26-15-8-7-14-25(23)26)31(40)37-28(33(42)43)19-24-13-9-10-16-34-24;/h7-10,13-16,20-22,27-29,35H,4-6,11-12,17-19H2,1-3H3,(H,36,39)(H,37,40)(H,42,43);1H/t27-,28-,29+;/m1./s1
Standard InChI Key: XCHDSFDJBASMSH-PURBPPSFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 589.74 | Molecular Weight (Monoisotopic): 589.3264 | AlogP: 3.86 | #Rotatable Bonds: 13 |
Polar Surface Area: 144.49 | Molecular Species: ACID | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 3.62 | CX Basic pKa: 4.61 | CX LogP: 2.96 | CX LogD: 0.70 |
Aromatic Rings: 3 | Heavy Atoms: 43 | QED Weighted: 0.24 | Np Likeness Score: -0.33 |
1. Doherty AM.. (1992) Endothelin: a new challenge., 35 (9): [PMID:1315867] [10.1021/jm00087a001] |
Source(1):